On the oncogenic activity of ethylene oxide and propylene oxide in mice. by Dunkelberg, H.
Br. J. Cancer (1979) 39, 588
Short Communication
ON THE ONCOGENIC ACTIVITY OF ETHYLENE OXIDE AND
PROPYLENE OXIDE IN MICE
H. DUNKELBERG
From the Institute of Hygiene, University of Mainz, Hochhaus am Augustusplatz,
D-6500 Mainz, Germany
Received 30 January 1979 Accepted 31 January 1979
THE EPOXIDES, ethylene oxide and pro-
pylene oxide are used extensively for
fumigation ofstored agricultural products.
Ethylene oxide, because of its effective
bactericidal properties, is used for the
sterilization of surgical equipment which
isheatlabile. Therefore, exposureofhuman
beings can occur in various ways. As
various monofunctional epoxides show an
oncogenic activity in animal tests (Druck-
rey et al., 1970; Van Duuren et al., 1963;
1966; 1967), a corresponding effect was
also expected with ethylene oxide and
propylene oxide. Walpole (1958) has
demonstratedthe carcinogenicity ofpropy-
lene oxide by s.c. injection into rats. In
the case of ethylene oxide, however, no
such effect has yet been determined.
Reyniers et al. (1964) supposed that there
might be a carcinogenic activity of ethy-
lene oxide in mice. They reported on a
colony of inbred germ-free albino mice
accidentally placed, for 150 days, on a
bedding of ground corncobs sterilized
with ethylene oxide. Over 90% of the
surviving, exposed females developed
tumours at various sites. No tumours
were reported in 83 female mice not
exposed to treated bedding. The authors
themselves, however, state that their
results must be regarded as observations
only, and do not constitute an experiment.
Until now the question of the carcino-
genicity of ethylene oxide has remained
unanswered. Because of the widespread
use ofethylene oxide and propylene oxide,
we regarded a test on a larger animal group
as necessary. As route of administration
we selected s.c. injection offemale NMRI-
mice (Ivanovas, Kisslegg, Germany). This
route makes it possible to apply exact
dosages and to differentiate easily between
tumours arising locally and tumours of
other organs. The incidence of spontane-
ous, subcutaneous tumours in NMRI-
mice is between 0 and 2% (Pott et al.,
1973). The compounds, ethylene oxide
(J. T. Baker Chemicals B.V., Deventer,
Holland) and propylene oxide (Merck-
Schuchardt, Muinchen, Germany) were
tested for impurities using the following
methods: infrared spectra, capillary
column gas chromatography and fluores-
cence spectra. 100 female NMRI-mice
were used per compound and dosage.
The solvent was tricaprylin (Roth,
Karlsruhe, Germany) cooled to 0°C. Treat-
ments were given by s.c. injection once
weekly in the interscapular area using
sterile tuberculin syringes and needles.
Ethylene oxide was administered in a
weekly dosage of 1P0 mg, 0 3 mg and
0-1 mg/animal, propylene oxide in a
weekly dosage of 2-5 mg, 1P0 mg, 0 3 mg
and 041 mg/animal. These quantities of
the compounds were contained in 0-1 ml
tricaprylin. For control purposes onegroup
was treated with tricaprylin only and one
group received no treatment. Up to now
the animals have beentreatedfor 91 weeks.
At present between 25% and 45% of the
animals used are still living in the various
test groups. The preliminary results of
the study are shown in the Table.
The Table shows that tumours appeared
at the injection site in the groups treated
with ethylene oxide and propylene oxide,
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TABLE.-S.C. injection of ethylene oxide and propylene oxide in mice. 100 animals/group
were given weekly injections of the compounds in 0'1 ml tricaprylin. Preliminary results
up to 91st week oftreatment
Single dose Total
Compound (mg) (mg/mouse) Neff Na Nb Ne
Ethylene oxide 10 91-0 77 75 12 12
0 3 27-3 92 58 8 16
0.1 9-1 85 64 6 9
Propylene oxide 2-5 227-5 81 68 15 17
1.0 91-0 89 63 11 20
0 3 27-3 88 58 2 14
0.1 9-1 80 62 3 16
Tricaprylin 01 ml 9-1 ml 83* 61 0 17
82t
No treatment 90* 55 0 16
88t
Neff: effective animal number: animals which were alive when the first animal died with tumour at the
injection site (for ethylene oxide after 50 weeks, for propylene oxide after 39 weeks).
Na: total number dead up to 91st week.
Nb: animals dead with tumour at the injection site.
Nc: animals dead with tumour at sites distant from the injection area.
* number of animals alive after 39 weeks.
t number of animals alive after 50 weeks.
the injection site were sarcomas. After
ethylene oxide, the first tumour appeared
in the 50th week, and after propylene
oxide in the 39th week. At the highest
dosages, 12 local tumours have occurred
with ethylene oxide and 15 with propylene
oxide. The Table also shows that, with an
increase of the total applied dosage the
number of subcutaneous tumours at the
injection site also increases. With low
dosages of propylene oxide, however, this
effect is no longer clear. At a total dosage
of 91-0 mg/animal the effect of ethylene
oxide corresponds to that of propylene
oxide. In the case of lower dosages ethy-
lene oxide seems to be more effective than
propylene oxide.
The number of tumours at sites distant
from the injection area is not significantly
greater in the groups treated with ethylene
oxide and propylene oxide than in the
controls. Previous evaluation has shown
that these tumours consist mainly of
lymphomas, both for treated and control
groups. At the end of this study, when all
results are available, the histological
results will be reported in detail. Our
results show that s.c. injections of mice
once a week with ethylene oxide and pro-
pylene oxide produced tumours at the
injection site, the yield corresponding to
dosage.
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